Risk Stratification

Related by string. risk stratification * risking . risked . Risks . risks . RISK . Risking . RISKS . r isk : High Risk Warning . Risk Factors section . Key Risk Ranking . heading Risk Factors . Item 1A Risk Factors . Youth Risk Behavior . Risk Ranking Declines . Industry Risk Score / stratification . stratifications : Social Stratification . Stratification * Rapid Risk Stratification *

Related by context. All words. (Click for frequent words.) 76 Clinical Outcome 75 Left Ventricular 73 Patients Undergoing 73 Differential Diagnosis 73 Myocardial Ischemia 72 Diabetic Foot Ulcer 72 Cardiotoxicity 72 Improves Survival 72 Venous Thromboembolism 72 Treating Chronic 72 Treatment Outcome 72 Coronary Angiography 72 Prognostic Value 72 Peripheral Arterial 71 Myocardial Perfusion 71 Diagnostic Criteria 71 Test Detects 71 Recurrent Breast Cancer 71 Ischemic Stroke 71 Prognostic Factors 71 Prospective Randomized 71 CT Angiography 71 Adjuvant Therapy 71 Clinical Trial Results 71 Septic Shock 71 Patients Receiving 71 Improves Outcomes 71 Severe Sepsis 70 Reduces Mortality 70 Laryngeal Cancer 70 Acute Myocardial Infarction 70 Unstable Angina 70 Diagnostic Tests 70 Oral Fingolimod 70 Adjuvant Chemotherapy 70 Thrombolysis 70 Renal Function 70 Patient Outcomes 70 Subgroup Analysis 70 Tyrosine Kinase Inhibitor 70 Ischemic 70 Adjuvant Treatment 70 Coronary Artery Calcium 70 Bone Metastases 70 Renal Artery 70 Shows Promise Against 70 Orthostatic Hypotension 70 Carotid Stenting 70 Thrombotic 70 Chronic Renal Failure 70 Contrast Enhanced 70 Aortic Valve Replacement 70 Heart Failure Patients 69 Hypercholesterolemia 69 RNAi Therapeutic 69 Acute Ischemic Stroke 69 Helps Predict 69 Drug Shows Promise 69 Breast Cancer Recurrence 69 Neoadjuvant Chemotherapy 69 Insulin Resistance 69 Thromboembolism 69 Appears Safe 69 Clinical Trial Data 69 Randomized Clinical Trial 69 Acute Coronary Syndromes 69 Invasive Breast Cancer 69 Novel Oral 69 transcranial Doppler ultrasound 69 Combination Treatment 69 Mouse Model 69 Tumor Targeting 69 Meta Analysis 69 Intracerebral Hemorrhage 69 Mortality Risk 69 Clinical Evaluation 69 Acute Heart Failure 69 Reperfusion 69 Lung Injury 69 Diabetic Nephropathy 69 Kidney Function 69 Psychiatric Illness 69 Diastolic Heart Failure 69 Atopic Dermatitis 69 Radiofrequency Ablation 69 Myelodysplastic Syndromes 69 Analytical Tool 69 Initiates Clinical Trial 69 Statistically Significant 69 Shows Promising 69 Hormone Refractory Prostate Cancer 69 Study Demonstrates 69 Genetic Marker 69 Targeted Therapy 69 Refractory Angina 69 Endometrial Cancer 69 Inflammatory Markers 69 Protein Expression 69 Clinical Validation 69 Predict Response 69 Transdermal Delivery 68 Hemodialysis Patients 68 Circulating Tumor Cells 68 Schizophrenia Treatment 68 Radiation Induced 68 Virus Infection 68 Node Positive 68 Novel Inhibitor 68 Relapsing Multiple Sclerosis 68 Treatment Reduces 68 Nicotine Vaccine 68 Therapy Reduces 68 Intravascular 68 Gastric Cancer 68 Demonstrates Sustained 68 Angiographic 68 Hepatocellular Carcinoma 68 ST Segment Elevation 68 Tumor Response 68 Non Invasive 68 Study Evaluating 68 Shows Efficacy 68 Randomized Controlled Trials 68 Renal Cancer 68 Demonstrates Positive 68 Pooled Analysis 68 Phase IIa Clinical Trial 68 Randomized Controlled Trial 68 Prolongs Survival 68 Myocardial Infarction 68 Liver Failure 68 Lowers Risk 68 Patients Treated With 68 Predict Risk 68 Carotid 68 Left Ventricular Dysfunction 68 Progenitor Cells 68 Renal Cell Carcinoma 68 Prostate Cancer Treatment 68 Localized Prostate Cancer 68 Clinical Trial Evaluating 68 Combo Therapy 68 Sipuleucel T 68 Aggressive Reduction 68 Therapeutic Efficacy 68 Image Guided 68 Rheumatoid Arthritis Patients 68 Progressive Multifocal Leukoencephalopathy 68 Proves Effective 68 Phase 2b Clinical Trial 68 Infarction 68 Potent Inhibitor 68 Antidepressant Treatment 68 Carotid Endarterectomy 67 Brain Metastases 67 Demonstrates Significant 67 Solid Tumors 67 Helps Diagnose 67 Valve Replacement 67 Stent Restenosis 67 Molecular Basis 67 Postmenopausal Women 67 Long Term Efficacy 67 Controlled Study 67 Minimally Invasive Treatment 67 Contrast Agent 67 Respiratory Distress 67 Controlled Trial 67 Depressive Symptoms 67 Randomized Study 67 Dendritic Cells 67 Sentinel Lymph Node Biopsy 67 Effective Treatments 67 Cardiovascular Events 67 Catheter Associated 67 Demonstrates Efficacy 67 Arterial Disease 67 Preclinical Data 67 Prognostic Significance 67 Unfractionated Heparin 67 Subtypes 67 Allogeneic 67 Less Invasive 67 Estrogen Receptor 67 Pulmonary Arterial Hypertension 67 Novel Compound 67 Hematological Cancers 67 Unresectable 67 Clinical Significance 67 DNA Methylation 67 Randomized Evaluation 67 Estrogen Therapy 67 Increased Mortality 67 Slow Progression 67 Occlusion 67 Medication Adherence 67 Demonstrates Potential 67 Chemotherapeutic Agents 67 Platelet Inhibition 67 Accelerated Partial Breast Irradiation 67 Disease Progression 67 Infarct 67 Orally Active 67 Intravesical 67 Acute Decompensated Heart Failure 67 Clinical Efficacy 67 FDA Approvals 67 Fungal Infections 67 Metabolic Disease 67 Skin Lesions 67 Placebo Controlled Trial 67 Novel Therapeutic 67 Aneurysm Repair 67 Chronic Heart Failure 67 Aurora Kinase 67 Contrast Agents 67 Immunostimulatory 67 Tumor Microenvironment 67 Stem Cell Treatment 67 Occlusive Disease 67 Endocrine Therapy 67 Carotid Artery Stenting 67 Main Outcome Measure 67 Catheter Ablation 67 Effectively Treats 67 Advanced Melanoma 67 Protein Linked 67 Randomized Trials 67 Cardiogenic Shock 67 Non Invasive Treatment 67 Embolization 67 Chronic Lymphocytic Leukemia 67 Dilated Cardiomyopathy 67 Clostridium difficile Infection 67 Inhaled Corticosteroids 67 Hospitalized Patients 67 Prognostic 67 Therapeutic Targets 67 Significantly Improves 67 Cardiovascular Outcomes 67 Intracranial Aneurysms 67 Neuroprotection 67 Hepatic Encephalopathy 67 Coronary Arteries 67 Data Suggest 67 Metabolic Disorder 67 Long Term Survival 67 Malignancy 67 Completes Patient Enrollment 67 Cognitive Impairment 67 Gene Mutation 67 Aortic Valve 67 Pathogenesis 67 Improve Survival 67 Psychiatric Disorders 67 Knee Osteoarthritis 67 Gene Variants 67 Treating Heart Failure 67 Node Negative 67 Investigational Treatment 67 Liver Metastases 67 Drug Candidate 67 Prospective Multicenter 67 Therapy Shows Promise 67 Genetic Variation 66 Venous Thrombosis 66 Anti Tumor 66 Ventricular Tachycardia 66 Amniotic Fluid 66 Cognitive Function 66 Echocardiographic 66 Antiviral Therapy 66 Help Detect 66 Biomarker Study 66 Stable Angina 66 Gene Linked 66 Oral Mucositis 66 Hsp# Inhibitor 66 Pharmacokinetic Study 66 Inhaled Nitric Oxide 66 Lung Cancer Drug 66 Study Validates 66 Multicenter 66 Pegylated Liposomal Doxorubicin 66 Phase 2b Study 66 Overactive Bladder 66 Remission Maintenance 66 Glucose Monitoring 66 Antiplatelet 66 Hypertensive Patients 66 Protease Inhibitor 66 Bladder Cancer 66 Homeostasis 66 Therapy Improves 66 Sleep Disturbance 66 Dose Escalation 66 Randomized Phase II 66 Cardiac Resynchronization 66 Phase IIb Clinical Trial 66 Coronary Artery Bypass Graft 66 HER2 Positive Breast Cancer 66 Antigen Specific 66 Abnormality 66 Inflammatory Arthritis 66 IND Filing 66 Achieves Primary Endpoint 66 Lupus Drug 66 Diabetic Neuropathy 66 Asthma Intervention 66 Autologous Stem Cell Transplantation 66 Hormone Receptor Positive 66 Pediatric Patients 66 Presents Preclinical Data 66 Glomerular Filtration Rate 66 Breast Cancer Treatment 66 Myocardial Infarction Study 66 Genes Involved 66 ST Elevation Myocardial 66 Modulates 66 Significantly Reduces 66 Neuroendocrine Tumors 66 Hematopoietic 66 ORLive Presents 66 Respiratory Virus 66 Safinamide 66 Systematic Review 66 Meets Primary Endpoint 66 Treating Depression 66 Breast Density 66 Autoimmune Disease 66 Inflammatory Disease 66 Genes Linked 66 Receives Orphan Drug Designation 66 Autoimmune Diseases 66 Breast Tissue 66 Genes Associated 66 Imaging Technique 66 Reduces Risk 66 Investigational Drug 66 Thromboembolic 66 Reduced Risk 66 Microalbuminuria 66 Phase III Clinical Trial 66 Physician Insights 66 Antitumor Activity 66 Percutaneous Coronary Intervention 66 Emerging Therapies 66 Protein Biomarker 66 Insulin Therapy 66 undergoing Percutaneous Coronary 66 Neurodegenerative Disease 66 Symptom Scale 66 Dual Antiplatelet Therapy 66 Renal Cell Cancer 66 Coronary Revascularization 66 See CLINICAL PHARMACOLOGY 66 Gets FDA Clearance 66 Preclinical Models 66 Diagnosis Treatment 66 Preclinical Study 66 Chronic Myelogenous Leukemia 66 Study Shows Benefits 66 Newly Diagnosed Multiple Myeloma 66 Diabetic Patients 66 Carotid Revascularization Endarterectomy vs. 66 Vertebral Fractures 66 Adenomas 66 Total Knee Arthroplasty 66 Chemotherapy Induced 66 Anti Tumor Activity 66 Helps Identify 66 Hyperlipidemia 66 Transdermal Patch 66 Hospital Acquired Pneumonia 66 Maven Semantic 66 Files IND 66 Lymph Node 66 Sleep Disturbances 65 Genetic Markers 65 Breast Carcinoma 65 Hernia Repair 65 Aggressive Drug Evaluation 65 Cost Effectiveness 65 Heart Transplant Recipients 65 Cognitive Problems 65 Abciximab 65 Bucindolol 65 Surgical Treatment 65 Levels Linked 65 Stress Induced 65 Adverse Event 65 Systolic Blood Pressure 65 Fracture Risk 65 Combination Therapy 65 Phase 2a Trial 65 Acute Coronary Syndrome 65 Lymphoid 65 Malignant Glioma 65 Myelodysplastic Syndrome 65 Data Extraction 65 Mimetics 65 Myoblast 65 MR Angiography 65 Renal Disease 65 Immunomedics Announces 65 Pharmacodynamics 65 Relapsing Remitting Multiple Sclerosis 65 Suicidality 65 Systemic Delivery 65 Iron Deficiency 65 Protein Synthesis 65 Inflammatory Pain 65 Vertebral Fracture 65 Investigational Compound 65 Comorbidity 65 Kinase Inhibitor 65 Radical Prostatectomy 65 Percutaneous Tibial Nerve Stimulation 65 Endovascular Repair 65 Immune Responses 65 Paroxysmal 65 Obese Patients 65 Immunomodulatory 65 Epithelial Cell 65 Proven Effective 65 Clinical Guideline 65 Breast Tumors 65 Beta Blocker 65 Lung Cancer Trial 65 Phase III Trial 65 Erythropoietic 65 Lung Cancer Patients 65 Statin Therapy 65 Protease Inhibitors 65 Breast Cancer Metastasis 65 Osteoporosis Drug 65 Study Casts Doubt 65 Etiology 65 Successfully Completes Phase 65 Treatment Resistant 65 Metastases 65 Myelofibrosis 65 Comorbidities 65 metastatic malignant 65 Cardiovascular Disease Risk 65 Kinase Inhibitors 65 Novel Treatments 65 dual endothelin receptor antagonist 65 Observational Study 65 Secondary Hyperparathyroidism 65 Therapeutic Antibody 65 Confirms Efficacy 65 Adenoma 65 Phase 2b Trial 65 Stent Thrombosis 65 Pharmacogenomic 65 Implantable Cardioverter Defibrillator 65 Therapeutic Intervention 65 Diagnostic Tools 65 #-# Full Text 65 Study Shows Significant 65 Metastatic Renal Cell Carcinoma 65 Reperfusion Injury 65 Stent Placement 65 Acute Stroke 65 Tumor Suppressor 65 Deep Venous Thrombosis 65 Endoluminal 65 Electrical Stimulation 65 Pregnancy Outcomes 65 Improves Quality 65 Present Preclinical Data 65 Mouse Models 65 Help Predict 65 Decompensated Heart Failure 65 Critical Limb Ischemia 65 Prostate Biopsy 65 Lipoprotein 65 Clinical Practice Guideline 65 Iron Overload 65 Signaling Pathways 65 Cervical Dysplasia 65 Drug Prevents 65 Prostate Cancer Patients 65 Cancer Vaccines 65 Helps Detect 65 Multicenter Trial 65 Main Outcome Measures 65 Breast Cancer Cells 65 Initiates Clinical 65 Polymorphism 65 Initiates Enrollment 65 Genetic Tests 65 Cancer Biomarkers 65 Hypertrophy 65 Myocardial Perfusion Imaging 65 Malignant Pleural Mesothelioma 65 RECIST Response Evaluation Criteria 65 Coronary Disease 65 Solid Tumor 65 Predict Breast Cancer 65 Cholesterol Lowering Drug 65 Pharmacologic 65 Periodontal Disease 65 Arrhythmogenic 65 Anti CD# Antibody 65 Could Detect 65 Colorectal Screening 65 Antiplatelet Therapy 65 Anticancer Drug 65 Chronic Sinusitis 65 Molecular Mechanism 65 Dose Response 65 Prostate Cancer Recurrence 65 Artificial Pancreas 65 Cognitive Decline 65 Acute Kidney 65 Eye Diseases 65 Functional Outcomes 65 Diagnostic Accuracy 65 Prostate Cancer Progression 65 Novel Method 65 Gene Variation 65 REMINDER ORLive Presents 65 Pivotal Clinical Trial 65 Placebo Controlled Study 65 Chronic Myeloid Leukemia 65 Phase Ib Clinical Trial 64 Abstract Accepted 64 Long Term Outcomes 64 Severe Asthma 64 Asthma Treatment 64 Intervention Effectiveness CATIE 64 Protein Structures 64 Total Hip Arthroplasty 64 Patency 64 Lung Cancer Treatment 64 Cardiac Ablation 64 Platelet Function 64 STRIDE PD 64 Renal Insufficiency 64 Hip Fracture 64 Predictive Value 64 Hematological Malignancies 64 Highly Accurate 64 Presents Positive 64 Early Diagnosis 64 Chronic Hepatitis C 64 Elderly Patients 64 Low Dose 64 Therapeutic Approaches 64 Left Atrial 64 Cell Adhesion 64 Breast Ultrasound 64 Intervention Trial 64 Well Tolerated 64 Organ Rejection 64 Neurodegenerative 64 Proves Successful 64 Metastatic Prostate Cancer 64 Chemoradiation 64 Blocked Arteries 64 Study Identifies 64 FDA Okays 64 Fibrosis 64 Tumor Growth 64 Genes Identified 64 Afib 64 Treatment Approaches 64 Patients Treated 64 II Clinical Trial 64 Fractional Flow Reserve 64 Magnetic Stimulation 64 Ventricular Arrhythmias 64 Pivotal Study 64 Glycemic Control 64 Smooth Muscle 64 Adjunctive 64 Often Misdiagnosed 64 Phase III AFFIRM 64 Treated Patients 64 Hemorrhagic Stroke 64 Chronic Pelvic Pain 64 Metastatic Melanoma 64 Slows Progression 64 Clinical Decision Making 64 Malignancies 64 Anticancer Drugs 64 Kidney Failure 64 Protease 64 Genetic Predisposition 64 RNAi Therapeutics 64 Neoplasms 64 Anticancer Activity 64 Previously Treated 64 Interpersonal Psychotherapy 64 Left Ventricular Hypertrophy 64 Prostatectomy 64 Antiangiogenic 64 Ultrasensitive 64 Inhibits 64 Exacerbation 64 Sudden Cardiac Death 64 Hematological 64 Skeletal Muscle 64 Treatment Regimen 64 Thyroid Hormone 64 Therapeutic Antibodies 64 Safety Tolerability 64 Intracranial 64 Pivotal Trial 64 Critically Ill Patients 64 Symptom Severity 64 Viral Infections 64 Coronary CTA 64 Clinical Outcomes 64 Improve Outcomes 64 Anticoagulation 64 Gender Differences 64 Tyrosine Kinase Inhibitors 64 Efficacy Trial 64 Myocardial Infarction TIMI 64 Drug Eluting 64 Outpatient Setting 64 Phenotypes 64 Prophylactic Treatment 64 Cell Lymphoma 64 Antiviral Activity 64 Urine Test 64 Inhaled Liposomal Ciprofloxacin 64 Optical Coherence Tomography 64 Osteoarthritis Patients 64 Detection Device 64 Boosts Survival 64 Further Validates 64 Replacement Therapy 64 Quantitation 64 Artery Disease 64 Infected Patients 64 Therapy Evaluation 64 Randomized Double Blind 64 Enlarged Prostate 64 Ultrasound Imaging 64 Stem Cell Transplants 64 Statin Drugs 64 Genes Predict 64 Treatment Algorithm 64 Autoimmune Disorders 64 Mitral Valve Repair 64 Acute Treatment 64 Novel Mechanism 64 Shown Effective 64 Cardiac Resynchronization Therapy 64 Renal Transplantation 64 Blood Pressure Monitoring 64 Cardiometabolic 64 Brain Stimulation 64 Immune Therapy 64 Prevent Stroke 64 Rheumatoid 64 Detecting Breast Cancer 64 Pulmonary Artery 64 Treatable 64 Initiates Phase III 64 Proteasome 64 Castration Resistant Prostate Cancer 64 Can Predict 64 Oral Cavity 64 Collaborators Present 64 Systemic Sclerosis 64 Randomized Controlled 64 Ischaemic 64 Completes Enrollment 64 Ocular Surface Disease 64 Granted Orphan Drug 64 IND Application 64 Clinical Relevance 64 Attenuates 64 Edge STudy 64 Initiates Phase II 64 NDA Submission 64 Novel Approaches 64 Oncolytic Reovirus 64 Mesothelioma Treatment 64 Pharmacogenetic 64 Embolic 64 Prostatic 64 SF #v# 64 Advanced Renal Cell 64 Blood Cancers 64 Functional Assessment 64 HCV Protease Inhibitor 64 Receptor Antagonists 64 Shows Statistically Significant 64 Gastrointestinal Disorders 64 Cervical Spine 64 Randomized Phase 64 Gene Expression Analysis 64 Detect Cancer 64 Mutational 64 Oxidative Stress 64 Cancer Incidence Mortality 64 Significantly Improved 64 Screening Tool 64 Aggressive Prostate Cancer 64 Multicenter Randomized 64 Patient Enrollment 64 Radiation Exposure 64 Thiazolidinediones 64 Polymerase Inhibitor 64 Cardiovascular Risk Reduction 64 Strongly Linked 64 Patellofemoral 64 Neoadjuvant 64 Guideline Update 63 Lesion 63 Enzyme Linked 63 HER2 Positive 63 Shows Promise 63 Conjugate 63 CaPSURE 63 Intra Arterial 63 Soft Tissue Sarcoma 63 Ovarian Cancer Patients 63 Newly Diagnosed 63 Biphasic 63 Laser Ablation 63 Aortic Dissection 63 Multicenter Study 63 Factor Receptor 63 Ovarian Cancers 63 Showed Significant 63 Anxiety Depression 63 Total Knee Replacement 63 Bare Metal Stent 63 Prolongs Life 63 Hyperkalemia 63 Randomized Double blind 63 Bosutinib 63 Aromatase Inhibitors 63 Phase 1b Clinical Trial 63 Tumor Progression 63 Virtual Colonoscopy 63 Imaging Techniques 63 Renal Impairment 63 Brain Atrophy 63 Vitro Diagnostic Multivariate 63 Nonalcoholic Fatty Liver Disease 63 Clinically Significant 63 Thrombus 63 Cardiac Imaging 63 Therapeutic Potential 63 Adverse Outcomes 63 Could Predict 63 fosbretabulin 63 Successfully Treated 63 Embolic Protection 63 Survival Benefit 63 Files Investigational 63 Dry Powder Inhalers 63 Study Examines 63 J Am Coll 63 Noninvasive Prenatal 63 Tumor Cells 63 Insulin Sensitivity 63 Prostate Cancer Diagnosis 63 Restenosis 63 Lymphocytic 63 Virologic 63 FDA Clears 63 Cytometry 63 Synthetic Peptide 63 Epilepsy Drug 63 Myeloma Patients 63 Single Dose 63 Pharmacodynamic 63 Coronary Calcium 63 Monotherapy 63 Ureteral 63 Malignant Melanoma 63 Extracellular Matrix 63 Aortic Aneurysm 63 Multiple Myeloma Patients 63 Unstable angina 63 Related Mortality 63 Study Analyzes 63 Enoxaparin 63 Small Molecule Inhibitors 63 Minimally Invasive Procedure 63 Cardiac Output 63 Immunosuppressant 63 AnaSpec Introduces 63 C Reactive Protein 63 Results Confirm 63 JAK Inhibitor 63 Outcome Measures 63 Treatment Shows Promise 63 Rotavirus Vaccine 63 BiTE Antibody 63 Sentinel Lymph Node 63 Dose Ranging Study 63 Immune Cell 63 Intravitreal 63 Balloon Angioplasty 63 Cerebrospinal Fluid 63 Viral Suppression 63 Preterm Labor 63 Non Responders 63 Angiogenic 63 Small Bowel 63 Liver Injury 63 Plaque Psoriasis 63 Natural Catastrophe Stress 63 Polyneuropathy 63 Neural Stem Cells 63 Lower Extremity 63 Osteoporosis Treatment 63 Lung Cancer Detection 63 Epithelial Ovarian Cancer 63 Files Patent Application 63 Gout Drug 63 Antiepileptic Drugs 63 Squamous Cell Carcinoma 63 Apoptotic 63 Protein Interactions 63 Fondaparinux 63 Asthma COPD 63 Double Blind Placebo 63 Aliskiren 63 Nesiritide 63 Aptamer 63 Endovascular Treatment 63 Osteoporosis Drugs 63 Ablation 63 Hormone Receptor 63 Treatment Naïve 63 FDA Approves Drug 63 Spinal Fluid 63 Signaling Pathway 63 Teva Provides Update 63 J Clin 63 Gene Silencing 63 Phase IIb Trial 63 Portal Hypertension 63 Chronic Rhinosinusitis 63 Investigational Agent 63 Genomic Grade 63 Menopausal Symptoms 63 Benign Prostatic Hyperplasia 63 Drug Combo 63 Prostate Cancer Detection 63 Ranolazine 63 Naive Patients 63 Heart Transplantation 63 Transplant Patients 63 Whole Genome Sequencing 63 #:#-#,# CrossRef Medline [002] 63 Researchers Uncover 63 HDAC Inhibitor 63 Immunosuppression 63 Prenatal Diagnosis 63 Hypotension 63 Drug Resistant 63 Initiate Clinical Trial 63 Hypertriglyceridemia 63 Viral Load 63 Scientists Identify 63 Insulin Delivery 63 Cholesterol Levels SPARCL 63 Hormone Therapy 63 Glycosylation 63 Genetic Disorder 63 Refractory Hodgkin Lymphoma 63 Panic Disorder 63 Non Alcoholic Steatohepatitis 63 Implantable Device 63 Phenotype 63 Synaptic Plasticity 63 Combination REOLYSIN R 63 Impairs 63 Histological 63 Elastography 63 Aortic Stenosis 63 Pancreas Cancer 63 Acute Renal Failure 63 Migraine Drug 63 International Prognostic Scoring 63 Sirolimus Eluting Stent 63 Recurrent Prostate Cancer 63 Immunotherapeutic 63 Chemoprevention 63 Immune Mediated 63 Protein Biomarkers 63 Juvenile Idiopathic Arthritis 63 Cancer Stem Cells 63 Histologic 63 Cytotoxicity 63 Sexual Satisfaction 63 Gestational Diabetes 63 Post Operative 63 Resistant Hypertension 63 Esophageal 63 Gene Variant 63 Chronic Bronchitis 63 Adult Stem Cell Therapy 63 Symptom Relief 63 Sapacitabine 63 Drug Fails 63 Gene Mutations 63 Fatty Liver 63 Lung Cancer Survival 63 Decitabine 63 Novel Small Molecule 63 Nerve Regeneration 63 Cystatin C 63 Novel Approach 63 Crystallographic 63 Intervention Effectiveness 63 Neurosurgical Products 63 Rectal Cancer 63 Molecular Mechanisms 63 CHMP Opinion 63 Clinical Practice Guidelines 63 Follicular Lymphoma 63 Pharmacologic Treatment 63 Breast Cancer Patients 63 Oligonucleotides 63 Cardiac Rhythm 63 Screening Mammography 63 Test Methodology 62 Small Molecule 62 Antihypertensive 62 Amino Acid 62 Submits NDA 62 Leukemia Cells 62 NSABP B 62 Predictive Toxicology 62 Demonstrated Significant 62 Randomized Clinical Trials 62 Advanced Heart Failure 62 Protein Interaction 62 Anthracycline 62 complement inhibitor eculizumab 62 Announces FDA Clearance 62 Preterm Birth 62 Is Well Tolerated 62 Generalized Anxiety Disorder 62 Valvular 62 Antitumor 62 Metabolic Endocrinology 62 Transcatheter 62 Endothelial 62 Preimplantation 62 Regenerative Cells 62 Allergic Rhinitis 62 Renal Tumors 62 Pancreatic Adenocarcinoma 62 Deforolimus 62 FDG-PET/CT 62 Neuroanatomy 62 Cancer Therapies 62 Neoplasia 62 Erythropoiesis Stimulating Agents ESAs 62 Mechanistic 62 Study Explores 62 Valvular Heart Disease 62 Atherosclerotic 62 Microwave Ablation System 62 Predict Prostate Cancer 62 Guidelines Issued 62 Hedgehog Pathway 62 Invasive Fungal Infections 62 Anticoagulant 62 Tumor Suppressor Gene 62 Subarachnoid hemorrhage 62 Epithelial 62 Cognitive Deficits 62 Bacteremia 62 Urinary Incontinence 62 Embolic Protection Device 62 Adjuvant 62 Radiation Dose 62 Watchful Waiting 62 Peripheral Artery Disease 62 Microvascular 62 Correlation Between 62 Adjuvant Breast Cancer 62 Demonstrate Significant 62 Neurocognitive 62 Epidermal Growth Factor Receptor 62 Eculizumab 62 Eluting 62 Study Compares 62 Psychological Stress 62 Ischemic Heart Disease 62 Receives FDA Clearance 62 Late Breaker 62 Pivotal Phase III 62 Transcriptome

Back to home page